| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2798206 | Diabetes Research and Clinical Practice | 2008 | 8 Pages |
Abstract
Adipocyte/macrophage fatty acid binding protein (A-FABP) has been shown to be closely associated with metabolic syndrome, obesity and development of atherosclerosis. Moreover, A-FABP has been recently suggested as a potential therapeutic target of these abnormalities in animal models. The present review aims to summarize current knowledge on A-FABP functions and regulations both in animal models and humans, since the role of A-FABP in human physiology and disease has not been presently clarified.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Eva Krušinová, Terezie Pelikánová,